Alluvi tirzepatide appears to have emerged as a promising therapeutic option for the control of metabolic disorders. This preclinical evaluation assessed the efficacy and profile of tirzepatide 40mg in animal models of insulin resistance. The studies demonstrated that tirzepatide 40mg significantly enhanced glycemic management and lowered insulin l